Hacker News Reader

That's the treatment that I got back in September in the US. I think they stopped using Remdesivir since then because it didn't correlate with any positive outcome. It also was destroying my liver, so they had to cut off the treatment halfway through.

https://www.forbes.com/sites/jvchamary/2021/01/31/remdesivir...

View on HN

Maybe the total balance of results is better for immunosuppressed oncologic patients.

Or maybe it is just a form of medical nationalism, given that the leader of the Remdesivir scientific team, Tomáš Cihlář, is a Czech scientist.

We had some critical patients improve and heal on remdesivir, though. I wonder how big of a role genetic diversity plays. There are many uncertain suspicions that Covid hits some people harder than others based not just on lifestyle, but things such as blood groups.

Research into that will be a good PhD material for years to come.

Reply on news.ycombinator.com